Trials / Conditions / Mucociliary Clearance

Mucociliary Clearance

7 registered clinical trials studyying Mucociliary Clearance.

Status	Trial	Sponsor	Phase
Completed	Study to Assess the Effect of the New HFA-152a Propellant on Mucociliary Clearance NCT05875025	Chiesi Farmaceutici S.p.A.	Phase 1
Completed	Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in He NCT05755932	AstraZeneca	Phase 3
Withdrawn	A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fi NCT01025713	Gilead Sciences	Phase 1
Completed	A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers NCT00999531	Gilead Sciences	Phase 1
Completed	A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers NCT00951522	Gilead Sciences	Phase 1
Completed	Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung NCT00902707	University of North Carolina, Chapel Hill	Phase 1
Completed	Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol NCT00325767	Johns Hopkins University	Phase 4